Skip to content

Exercise therapy using lumbar type HAL for patients with disuse syndrome

The Efficacy of Exercise Therapy Using lumbar type HAL to Improve ADL in Patients with Disuse Syndrome -A Multicenter Prospective Intervention Trial-.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032220541
Enrollment
60
Registered
2022-12-26
Start date
2022-12-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disuse syndrome

Interventions

Rehabilitation consisting of (1) forward bending training, (2) pelvic tilt training, (3) standing training, and (4) squat training using HAL waist type for a total of 10 sessions of 15 minutes per ses

Sponsors

Miura Kousei
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Persons admitted to the Community Comprehensive Care Unit (2) Persons who can give written consent of their own free will (3) Men and women between the ages of 65 and 100 (4) Persons with disuse syndrome at or above the level of sitting assistance (FIM transfer operation 3-5 as a guide) 5) Persons who can wear HAL waist type. (Height about 140 to 180 cm, Weight about 40 to 80 kg, Abdominal circumference 120 cm or less, Mid-thigh circumference 80 cm or less, Pelvic width 39 cm or less)

Exclusion criteria

Exclusion criteria: 1) Persons using active implanted medical devices such as cardiac pacemakers 2) Patients with serious complications for which exercise therapy is not indicated. For example, heart failure with oxygen administration, respiratory failure, ischemic heart disease with symptoms, non-compensated liver cirrhosis, poorly controlled diabetes, hypertension, etc. (3) Patients who have difficulty making free-will decisions to participate or not participate in the research due to impaired consciousness, severe dementia, etc., or who have difficulty performing effective exercise therapy. (4) Persons who are unable to apply HAL bioelectrodes due to skin diseases, etc. (5) Other patients whom the principal investigator or subinvestigator determines to be inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Efficacy of Exercise Therapy Using HAL Waist Type Percentage of responders whose Timed Up and Go test (TUG) was shortened by 3.4 seconds or more at the end of exercise therapy compared to before the start of exercise therapy.

Secondary

MeasureTime frame
Mobility function (Barthel index (BI), five times stand test (SS-5), Functional Independence Measure (FIM)) was evaluated before the study, at the end of the study, and at follow-up (1 week and 2 weeks after the end of exercise therapy) by exercise therapy intervention using HAL waist type. Mobility function (Barthel index (BI), five-stance test (SS-5), and Functional Independence Measure (FIM)) were assessed before, at the end of, and at follow-up (1 week and 2 weeks after the end of exercise therapy) using TUG and HAL waist type exercise therapy intervention. The patients were evaluated before the start of the study, at the end of the study, and at the follow-up (1 week and 2 weeks after the end of exercise therapy). Evaluation of treatment effect by underlying disease Safety of exercise therapy using HAL hip type for disuse syndrome (evaluation of the occurrence of diseases during the exercise therapy as follows) (1) The occurrence of other illnesses, etc.

Contacts

Public ContactKousei Miura

University of Tsukuba Hospital

kmiura@tsukuba-seikei.jp+81-29-853-3219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026